Selected research
Industry Research
Bilastine Industry Research Report 2026
Market perspective
The global Bilastine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bilastine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bilastine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bilastine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bilastine include Aralez Pharmaceuticals, Berlin Chemie, Faes Farma, Menarini, Pierre Fabre, Taiho Yakuhin, GlaxoSmithKline and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bilastine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bilastine Market by Company
Aralez Pharmaceuticals
Berlin Chemie
Faes Farma
Menarini
Pierre Fabre
Taiho Yakuhin
GlaxoSmithKline
Takeda
Bilastine Segment by Type
Hospital
Drug Store
Bilastine Segment by Application
Allergic Rhinoconjunctivitis
Allergic Rhinitis
Urticaria
Bilastine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bilastine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bilastine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bilastine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bilastine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bilastine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bilastine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hospital
- Drug Store
Applications
- Allergic Rhinoconjunctivitis
- Allergic Rhinitis
- Urticaria
Companies covered
- Aralez Pharmaceuticals
- Berlin Chemie
- Faes Farma
- Menarini
- Pierre Fabre
- Taiho Yakuhin
- GlaxoSmithKline
- Takeda
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bilastine Market Size (2021-2032)
- 2.2.2 Global Bilastine Sales (2021-2032)
- 2.2.3 Global Bilastine Market Average Price (2021-2032)
- 2.3 Bilastine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Hospital
- 2.3.3 Drug Store
- 2.4 Bilastine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Allergic Rhinoconjunctivitis
- 2.4.3 Allergic Rhinitis
- 2.4.4 Urticaria
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bilastine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bilastine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Bilastine Revenue of Manufacturers (2021-2026)
- 3.4 Global Bilastine Average Price by Manufacturers (2021-2026)
- 3.5 Global Bilastine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bilastine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bilastine, Product Type & Application
- 3.8 Global Manufacturers of Bilastine, Established Date
- 3.9 Global Bilastine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aralez Pharmaceuticals
- 4.1.1 Aralez Pharmaceuticals Company Information
- 4.1.2 Aralez Pharmaceuticals Business Overview
- 4.1.3 Aralez Pharmaceuticals Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Aralez Pharmaceuticals Bilastine Product Portfolio
- 4.1.5 Aralez Pharmaceuticals Recent Developments
- 4.2 Berlin Chemie
- 4.2.1 Berlin Chemie Company Information
- 4.2.2 Berlin Chemie Business Overview
- 4.2.3 Berlin Chemie Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Berlin Chemie Bilastine Product Portfolio
- 4.2.5 Berlin Chemie Recent Developments
- 4.3 Faes Farma
- 4.3.1 Faes Farma Company Information
- 4.3.2 Faes Farma Business Overview
- 4.3.3 Faes Farma Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Faes Farma Bilastine Product Portfolio
- 4.3.5 Faes Farma Recent Developments
- 4.4 Menarini
- 4.4.1 Menarini Company Information
- 4.4.2 Menarini Business Overview
- 4.4.3 Menarini Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Menarini Bilastine Product Portfolio
- 4.4.5 Menarini Recent Developments
- 4.5 Pierre Fabre
- 4.5.1 Pierre Fabre Company Information
- 4.5.2 Pierre Fabre Business Overview
- 4.5.3 Pierre Fabre Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pierre Fabre Bilastine Product Portfolio
- 4.5.5 Pierre Fabre Recent Developments
- 4.6 Taiho Yakuhin
- 4.6.1 Taiho Yakuhin Company Information
- 4.6.2 Taiho Yakuhin Business Overview
- 4.6.3 Taiho Yakuhin Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Taiho Yakuhin Bilastine Product Portfolio
- 4.6.5 Taiho Yakuhin Recent Developments
- 4.7 GlaxoSmithKline
- 4.7.1 GlaxoSmithKline Company Information
- 4.7.2 GlaxoSmithKline Business Overview
- 4.7.3 GlaxoSmithKline Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GlaxoSmithKline Bilastine Product Portfolio
- 4.7.5 GlaxoSmithKline Recent Developments
- 4.8 Takeda
- 4.8.1 Takeda Company Information
- 4.8.2 Takeda Business Overview
- 4.8.3 Takeda Bilastine Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Takeda Bilastine Product Portfolio
- 4.8.5 Takeda Recent Developments
5 Global Bilastine Market Scenario by Region
- 5.1 Global Bilastine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bilastine Sales by Region: 2021-2032
- 5.2.1 Global Bilastine Sales by Region: 2021-2026
- 5.2.2 Global Bilastine Sales by Region: 2027-2032
- 5.3 Global Bilastine Revenue by Region: 2021-2032
- 5.3.1 Global Bilastine Revenue by Region: 2021-2026
- 5.3.2 Global Bilastine Revenue by Region: 2027-2032
- 5.4 North America Bilastine Market Facts & Figures by Country
- 5.4.1 North America Bilastine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bilastine Sales by Country (2021-2032)
- 5.4.3 North America Bilastine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Bilastine Market Facts & Figures by Country
- 5.5.1 Europe Bilastine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bilastine Sales by Country (2021-2032)
- 5.5.3 Europe Bilastine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Bilastine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bilastine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bilastine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bilastine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bilastine Market Facts & Figures by Country
- 5.7.1 South America Bilastine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bilastine Sales by Country (2021-2032)
- 5.7.3 South America Bilastine Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Bilastine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bilastine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bilastine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bilastine Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Bilastine Sales by Type (2021-2032)
- 6.1.1 Global Bilastine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Bilastine Sales Market Share by Type (2021-2032)
- 6.2 Global Bilastine Revenue by Type (2021-2032)
- 6.2.1 Global Bilastine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bilastine Revenue Market Share by Type (2021-2032)
- 6.3 Global Bilastine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bilastine Sales by Application (2021-2032)
- 7.1.1 Global Bilastine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Bilastine Sales Market Share by Application (2021-2032)
- 7.2 Global Bilastine Revenue by Application (2021-2032)
- 7.2.1 Global Bilastine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bilastine Revenue Market Share by Application (2021-2032)
- 7.3 Global Bilastine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bilastine Value Chain Analysis
- 8.1.1 Bilastine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bilastine Production Mode & Process
- 8.2 Bilastine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bilastine Distributors
- 8.2.3 Bilastine Customers
9 Global Bilastine Analyzing Market Dynamics
- 9.1 Bilastine Industry Trends
- 9.2 Bilastine Industry Drivers
- 9.3 Bilastine Industry Opportunities and Challenges
- 9.4 Bilastine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst